Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Aquita 150 SR
Active Ingredient: Bupropion hydrochloride 150mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Pharmaceuticals Inc, West Virginia, United States of America
Product: PipTaz BNM
Active Ingredients: Piperacillin monohydrate 4000mg
Tazobactam 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Mitim SrL, Brescia, Italy
Product: Xifaxan
Active Ingredient: Rifaximin 550mg
Dosage Form: Film coated tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Alfa Wasserman SpA, Alanno, Italy
Dated this 25th day of July 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).